英文論文
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
2020
Takashima K, Fujii S, Komatsuzaki R, Komatsu M, Takahashi M, Kojima T, Daiko H, Minashi K, Chiwaki F, Muto M, Sasaki H, Yano T.
CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer.
Int J Oncol. 2020 Mar;56(3):835-847.
Shinya Ohashi, Osamu Kikuchi, Yukie Nakai, Tomomi Ida, Tomoki Saito, yuki Kondo, Yoshihiro Yamamoto, Yosuke Mitani, Trang H. Nguyen Vu, Keita Fukuyama, Hiroshi Tsukihara, Norihiko Suzuki, Manabu Muto.
Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma.
Mol Cancer Ther. 2020 Jun;19(6):1363-1372.
Sethi NS, Kikuchi O, Duronio GN, Stachler MD, McFarland JM, Ferrer-Luna R, Zhang Y, Bao C, Bronson R, Patil D, Sanchez-Vega F, Liu JB, Sicinska E, Lazaro JB, Ligon KL, Beroukhim R, Bass AJ.
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.
Nat Genet. 2020 Feb;52(2):219-230.
Kiichiro Baba, Motoo Nomura, Shinya Ohashi, Takuya Hiratsuka, Yukie Nakai, Tomoki Saito, Yuki Kondo, Keita Fukuyama, Osamu Kikuchi, Atsushi Yamada, Junichi Matsubara, Kenshiro Hirohashi, Yosuke Mitani, Ayaka Mizumoto, Manabu Muto.
Experimental model for the irradiation-mediated abscopal effect and factors influencing this effect.
Am J Cancer Res 2020 Feb 1;10(2):440-453.
Nomura M, Oze I, Masuishi T, Yokota T, Satake H, Iwasawa S, Kato K, Andoh M.
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.
Int J Clin Oncol. 2020 May;25(5):972-977.
Kakiuchi N, Yoshida K, Uchino M, Kihara T, Akaki K, Inoue Y, Kawada K, Nagayama S, Yokoyama A, Yamamoto S, Matsuura M, Horimatsu T, Hirano T, Goto N, Takeuchi Y, Ochi Y, Shiozawa Y, Kogure Y, Watatani Y, Fujii Y, Kim SK, Kon A, Kataoka K, Yoshizato T, Nakagawa MM, Yoda A, Nanya Y, Makishima H, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Sugihara E, Sato TA, Maruyama T, Miyoshi H, Taketo MM, Oishi J, Inagaki R, Ueda Y, Okamoto S, Okajima H, Sakai Y, Sakurai T, Haga H, Hirota S, Ikeuchi H, Nakase H, Marusawa H, Chiba T, Takeuchi O, Miyano S, Seno H, Ogawa S.
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis.
Nature. 2020 Jan;577(7789):260-265.
Uneno Y, Sato K, Morita T, Nishimura M, Ito S, Mori M, Shimizu C, Horie Y, Hirakawa M, Nakajima TE, Tsuneto S, Muto M.
Current status of integrating oncology and palliative care in Japan: a nationwide survey.
BMC Palliat Care. 2020 Jan 24;19(1):12.
Tomohiro Kondo, Shigemi Matsumoto, Keitaro Doi, Motoo Nomura, Manabu Muto.
Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: Case report.
CVIR Endovasc. 2020 Jan 6;3(1):2.
Yoshihiro Yamamoto, Masashi Kanai, Tadayuki Kou, Aiko Sugiyama, Eijiro Nakamura, Hidehiko Miyake, Takahiro Yamada, Masakazu Nishigaki, Tomohiro Kondo, Hiromi Murakami, Masako Torishima, Shigemi Matsumoto, Shinji Kosugi, and Manabu Muto.
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.
J Hum Genet. 2020 Jan;65(2):125-132.